DENVER, Nov. 2, 2010 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, today announced they have been invited to present at the 138th Annual Meeting of the American Public Health Association in Denver, CO on Wednesday, November 10, 2010. The Company will discuss the benefits of its nutritional supplement program for HIV/AIDS patients.
The Annual Meeting of the American Public Health Association is one of the oldest and largest public health meetings in the nation. Representatives of Federal and State health agencies will attend, including the FDA, CDC, NIH, CMS, and the Department of Health and Human Services among others.
MusclePharm's presentation panel discussion will discuss Innovative Approaches to Therapeutic HIV Design and will illustrate how nutritional supplementation has a positive effect on patients with AIDS Wasting Syndrome.
Dr. Roscoe M. Moore Jr., MusclePharm's Chief Scientific Director and former Assistant U.S. Surgeon General, commented, "MusclePharm is pleased to participate in the American Public Health Association's Annual Meeting. Therapeutic nutritional supplementation products, like those provided by MusclePharm, are essential in maintaining the health status of HIV/AIDS patients receiving antiretroviral therapies."
Dr. Moore continued, "MusclePharm continues to work to provide the most effective evidenced-based approach to produce products that will further mitigate the impact and progression of wasting syndrome in HIV/AIDS patients."
The U.S. Health Resources and Services Administration (HRSA) found that weight loss and muscle wasting remain a significant nutritional concern for people with HIV/AIDS. HRSA said, "HIV associated wasting results in loss primarily of lean body mass. Such depletion increases the likelihood of opportunistic infections and is an independent predictor of increased morbidity and mortality, even if total body weight is maintained."
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit .
MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.
CONTACT: ICR Investor Contact: John Mills, Senior Managing Director 310.954.1105